Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chantix in Ambivalent Smokers
NCT00595868Phase 2Completed
- Sponsor
- University of Vermont Medical Center
- Start
- Mar 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of varenicline in Tobacco Use Disorder (TUD), sponsored by University of Vermont Medical Center. Primary endpoint: Number of Participants With a Quit Attempt at 24 weeks. Started Mar 2008; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00595868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00595868.